Cardiac Surgical ProceduresREPLICCARNCT05363696
The REPLICCAR Registry and The Statewide Quality Improvement Initiative
An observational study of Cardiac Surgical Procedures, run by University of Sao Paulo General Hospital at 2 sites in Brazil.
Trial summary
Cardiovascular diseases remain the leading cause of death for the healthcare system and cardiac surgery has an important impact on their resolubility. Healthcare systems in the world have evolved to optimize their clinical records and thus learn from the real world through the interactivity between results, processes… Read more about this study
- Who is it for?
- Ages 18 to 90 years
- Conditions the study is for
- Cardiac Surgical Procedures
- What is being tested?
- Coronary artery bypass grafting (CABG) and Heart valve surgery
- Type of treatment
- Surgery or procedure
- How many people
- 9,723 participants
- Where
- 2 sitesBrazil
- Study dates
- 1 Aug 2013to 1 Aug 2019
- How long will I take part?
- 30 Days
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 90 years
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: Adult patients (18-90 years old) underwent cardiac surgery.
Who may be able to join
- Age 18- 90 years old.
- CABG or heart valve surgery
- Agreement to participate in the study signing informed consent documentation.
Who cannot join
- Re-operation
- Impossibility to access data variables relevant to the study.
Trial locations and contacts
2 sites in 1 country.
Brazil2 sites
USP Heart Institute
São Paulo, 05403-900
Fabio B Jatene, MD, PhD
São Paulo, 05409011
About this study
Official title: Paulista Cardiovascular Surgery Registry (REPLICCAR)
Cardiovascular diseases remain the leading cause of death for the healthcare system and cardiac surgery has an important impact on their resolubility. Healthcare systems in the world have evolved to optimize their clinical records and thus learn from the real world through the interactivity between results, processes, and structure. When the rate of growth of healthcare costs scenario is greater than the one of Gross Domestic Product of countries, there is a considerable challenge to increment the quality of healthcare services and the primordial patient safety, as well as the necessary control and traceability of implantable devices. The association and correlation of patients' demographic and clinically relevant information with the resources required for the care provided for each stratum represent the possibility to adapt, improve and innovate the healthcare programs; This will allow improving the optimization of the therapeutic protocols and the creation of related research areas, aiming to promote more equitable resources allocation, increase access and effectiveness, as well as to ascertain the magnitude of available and used resources and its impact.
Read the detailed description
METHODS Extension Cohort study, mandatory, prospective multicenter, in the state of São Paulo and of registry of consecutive cases. Besides the situational diagnostic of the results and comparison between the mean of both registries, there will be the creation of improvement reports for each of the REPLICCAR centers.
Next, quality improvement initiatives will be implemented in each center indicated by the reports.
Sample
- Will be included in a consecutive way all patients that had CABG and heart valve surgery in the participant centers for the defined period;
- Data will be collected, independently of surgical volume, severity status, and social condition among others, in sight of the São Paulo state health department;
- This way, it will be possible to produce a predictive curve to be used in most clinical case scenarios observed in the state of São Paulo;
- Conditions
- Cardiac Surgical Procedures
- Being tested
- Coronary artery bypass grafting (CABG), Heart valve surgery
- Keywords
- Database, Quality improvement, Mortality, Coronary artery bypass grafting, Heart valve surgery
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Coronary artery bypass grafting (CABG)Procedure or surgery
Coronary artery bypass grafting surgery procedure
Heart valve surgeryProcedure or surgery
Heart valve surgery procedure
What is being measured
The primary outcome is the main question the study is designed to answer.
Create and implementing data driven quality initiatives for cardiac surgery procedures in São Paulo state
Guided by the database, quality initiatives will be built in order to reduce mortality, length of stay and complications in the centers participating in REPLICCAR.
Measured: 5 years
Secondary outcomes (3)
Create a morbidity and mortality risk score
Create a morbidity and mortality risk score, in order to guide the care and interventions of patients undergoing cardiac procedures, in order to prevent morbidity and mortality outcomes.
Measured: 5 years
Long-term follow-up of patients included in the database
Long-term follow-up of patients included in the database, providing an opportunity to assess quality of life, evolution and deaths after hospital discharge.
Measured: 10 years
Assessment of the impact of patients' socioeconomic variation in its surgical evolution
Assessment of the impact of patients' socioeconomic variation on their evolution in terms of morbidity and mortality (short and long term).
Measured: 10 years
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted6 May 2022
- Study start1 Aug 2013
- Primary completion1 Sep 2016
- Study completion1 Aug 2019
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (2)Papers the sponsor has linked to this study.
- Other trials for Cardiac Surgical ProceduresStudies of the same condition, open and under way.
- More trials run by University of Sao Paulo General HospitalThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 9,723 participants (actual)
- Target duration
- 30 Days
Sponsor and investigators
- Lead sponsor
- University of Sao Paulo General Hospital
- Sponsor type
- University, hospital or other
- Collaborators
- University of Sao Paulo, Hospital Samaritano Paulista, Hospital Israelita Albert Einstein, Beneficência Portuguesa de São Paulo, Instituto Dante Pazzanese de Cardiologia, Hospital das Clinicas da Universidade Estadual de Campinas, Hospital de Base, Irmandade da Santa Casa de Misericórdia de Marília, Irmandade da Santa Casa de Misericórdia de São Paulo, Irmandade da Santa Casa de Misericórdia de Piracicaba, Hospital São Paulo da Universidade Federal de São Paulo, Hospital Pitangueiras do Grupo SOBAM
- Responsible party
- Sponsor
- Investigators
- Omar AV Mejia, MD,PhD, Principal investigator, USP Heart Institute
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05363696
- Sponsor's protocol ID
- 450617006
- Acronym
- REPLICCAR
- Status last verified
- May 2019
- First submitted
- 2 May 2022
- Last updated
- 25 May 2022
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No: The Comissão de Ética para Análise de Projetos de Pesquisa (CAPPesq) - HC-FMUSP https://www.hc.fm.usp.br/index.php?option=com\_content\&view=article\&id=243:comissao-de-etica-para-analise-de-projetos-de-pesquisa-do-hcfmusp\&catid=23\&Itemid=229 ) approved this analysis as part of the Project: "Surgical Risk Stratification as an Instrument for Innovation in Cardiac Surgery Programs in the Unified Health System of the São Paulo State " (REPLICCAR 1) under online registration Nº.450617006. This retrospective analysis was performed without identifying the patients. Therefore, patients' informed consent form was waived.
Publications
Orlandi BMM, Mejia OAV, Borgomoni GB, Goncharov M, Rocha KN, Bassolli L, Melo de Barros E Silva PG, Nakazone MA, Sousa A, Campagnucci VP, de Sousa Vilarinho KA, Katz M, Tiveron MG, Arrais Dos Santos M, Lisboa LAF, Dallan LAO, Jatene FB; REPLICCAR II Study Group. REPLICCAR II Study: Data quality audit in the Paulista Cardiovascular Surgery Registry. PLoS One. 2020 Jul 10;15(7):e0223343. doi: 10.1371/journal.pone.0223343. eCollection 2020.
PubMed 32649718Borgomoni GB, Dias RD, de Barros E Silva PGM, Nakazone MA, de Oliveira MAP, Campagnucci VP, Tiveron MG, Lisboa LAF, Hajjar LA, Zubelli JP, Jatene FB, Mejia OAV; REPLICCAR study group. Incidence of failure-to-rescue after coronary artery bypass grafting: a multicenter observational study from the REPLICCAR II registry in Brazil. Patient Saf Surg. 2025 Feb 11;19(1):6. doi: 10.1186/s13037-024-00417-9.
PubMed 39934891
Study at a glance
From the registry record, last updated by the sponsor on 25 May 2022. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Paulista Cardiovascular Surgery Registry (REPLICCAR)
- ClinicalTrials.gov ID
- NCT05363696
- Acronym / sponsor ID
- REPLICCAR / 450617006
- Conditions
- Cardiac Surgical Procedures
- Keywords
- Database, Quality improvement, Mortality, Coronary artery bypass grafting, Heart valve surgery
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 9,723 participants (actual)
- Lead sponsor
- University of Sao Paulo General HospitalUniversity, hospital or other
- Collaborators
- University of Sao Paulo, Hospital Samaritano Paulista, Hospital Israelita Albert Einstein, Beneficência Portuguesa de São Paulo, Instituto Dante Pazzanese de Cardiologia, Hospital das Clinicas da Universidade Estadual de Campinas, Hospital de Base, Irmandade da Santa Casa de Misericórdia de Marília, Irmandade da Santa Casa de Misericórdia de São Paulo, Irmandade da Santa Casa de Misericórdia de Piracicaba, Hospital São Paulo da Universidade Federal de São Paulo, Hospital Pitangueiras do Grupo SOBAM
- Study start
- 1 Aug 2013 (actual)
- Primary completion
- 1 Sep 2016 (actual)
- Study completion
- 1 Aug 2019 (actual)
- First posted
- 6 May 2022 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Cardiovascular diseases remain the leading cause of death for the healthcare system and cardiac surgery has an important impact on their resolubility. Healthcare systems in the world have evolved to optimize their clinical records and thus learn from the real world through the interactivity between results, processes, and structure. When the rate of growth of healthcare costs scenario is greater than the one of Gross Domestic Product of countries, there is a considerable challenge to increment the quality of healthcare services and the primordial patient safety, as well as the necessary control and traceability of implantable devices. The association and correlation of patients' demographic and clinically relevant information with the resources required for the care provided for each stratum represent the possibility to adapt, improve and innovate the healthcare programs; This will allow improving the optimization of the therapeutic protocols and the creation of related research areas, aiming to promote more equitable resources allocation, increase access and effectiveness, as well as to ascertain the magnitude of available and used resources and its impact.
Detailed description
METHODS Extension Cohort study, mandatory, prospective multicenter, in the state of São Paulo and of registry of consecutive cases. Besides the situational diagnostic of the results and comparison between the mean of both registries, there will be the creation of improvement reports for each of the REPLICCAR centers.
Next, quality improvement initiatives will be implemented in each center indicated by the reports.
Sample
- Will be included in a consecutive way all patients that had CABG and heart valve surgery in the participant centers for the defined period;
- Data will be collected, independently of surgical volume, severity status, and social condition among others, in sight of the São Paulo state health department;
- This way, it will be possible to produce a predictive curve to be used in most clinical case scenarios observed in the state of São Paulo;
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
- Target follow-up
- 30 Days
Who may qualify
- Ages
- 18 to 90 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- Adult patients (18-90 years old) underwent cardiac surgery.
Key inclusion criteria (3 listed)
- Age 18- 90 years old.
- CABG or heart valve surgery
- Agreement to participate in the study signing informed consent documentation.
Key exclusion criteria (2 listed)
- Re-operation
- Impossibility to access data variables relevant to the study.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Coronary artery bypass grafting (CABG)Coronary artery bypass grafting surgery procedure | Procedure or surgery | – |
| Heart valve surgeryHeart valve surgery procedure | Procedure or surgery | – |
Primary outcome
Create and implementing data driven quality initiatives for cardiac surgery procedures in São Paulo state
Time frame: 5 years
Guided by the database, quality initiatives will be built in order to reduce mortality, length of stay and complications in the centers participating in REPLICCAR.
3 secondary outcomes
Create a morbidity and mortality risk score
Time frame: 5 years
Long-term follow-up of patients included in the database
Time frame: 10 years
Assessment of the impact of patients' socioeconomic variation in its surgical evolution
Time frame: 10 years
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 25 May 2022.
- Results publication: PubMed 32649718Orlandi BMM, Mejia OAV, Borgomoni GB, Goncharov M, Rocha KN, Bassolli L, Melo de Barros E Silva PG, Nakazone MA, Sousa A, Campagnucci VP, de Sousa Vilarinho KA, Katz M, Tiveron MG, Arrais Dos Santos M, Lisboa LAF, Dallan LAO, Jatene FB; REPLICCAR II Study Group. REPLICCAR II Study: Data quality audit in the Paulista Cardiovascular Surgery Registry. PLoS One. 2020 Jul 10;15(7):e0223343. doi: 10.1371/journal.pone.0223343. eCollection 2020.
- Derived from this study: PubMed 39934891Borgomoni GB, Dias RD, de Barros E Silva PGM, Nakazone MA, de Oliveira MAP, Campagnucci VP, Tiveron MG, Lisboa LAF, Hajjar LA, Zubelli JP, Jatene FB, Mejia OAV; REPLICCAR study group. Incidence of failure-to-rescue after coronary artery bypass grafting: a multicenter observational study from the REPLICCAR II registry in Brazil. Patient Saf Surg. 2025 Feb 11;19(1):6. doi: 10.1186/s13037-024-00417-9.
- Individual participant dataSharing planned: No. The Comissão de Ética para Análise de Projetos de Pesquisa (CAPPesq) - HC-FMUSP https://www.hc.fm.usp.br/index.php?option=com_content\&view=article\&id=243:comissao-de-etica-para-analise-de-projetos-de-pesquisa-do-hcfmusp\&catid=23\&Itemid=229 ) approved this analysis as part of the Project: "Surgical Risk Stratification as an Instrument for Innovation in Cardiac Surgery Programs in the Unified Health System of the São Paulo State " (REPLICCAR 1) under online registration Nº.450617006. This retrospective analysis was performed without identifying the patients. Therefore, patients' informed consent form was waived.
Related trials for Cardiac Surgical Procedures
Active, not recruiting
Shockwave™ vs Surgical Endarterectomy for Calcified Severe Common Femoral Artery Stenosis: Comparison of Efficacy, Safety and Long-Term Outcomes
Common Femoral Artery Stenosis, Calcification; Heart
Not yet recruitingObservational study
Systematic Intraoperative Cell Salvage in On-Pump Cardiac Surgery Within a Mature Patient Blood Management Programme
Cardiac Surgical Procedures, Blood Transfusion
Recruiting
Change in Platelet Lipid Metabolism and Procoagulant Phenotype Induced by Cardiopulmonary Bypass. Impact on Postoperative Inflammatory Response and Bleeding Complications During Cardiac Surgery.
Cardiac Surgery, Cardiopulmonary Bypass
Not yet recruiting
Effect of Warm Footbath Combined With Relaxation Exercise on Pain and Anxiety During Chest Tube Removal After Cardiac Surgery
Chest Tube Removal
RecruitingObservational study
The Impact of Fast-Track Anesthesia on Postoperative Neurocognitive Function in Patients Undergoing Cardiac Surgery
Delirium - Postoperative, Cardiac Surgery
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Omar AV Mejia, MD,PhD principal investigator
USP Heart Institute
2 sites in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Cardiac Surgical Procedures, run by University of Sao Paulo General Hospital at 2 sites in Brazil.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 25 May 2022. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 2 sites in Brazil. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Create and implementing data driven quality initiatives for cardiac surgery procedures in São Paulo state (time frame: 5 years). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT05363696, which also lists 2 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 25 May 2022.